Pharmaceutical outsourcing: An upward trajectory

2^nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

November 23-24, 2012 Hyderabad International Convention Centre, India

Anand Manne

Accepted Abstracts: Pharmaceut Reg Affairs

Abstract :

Pharmaceutical manufacturing remains one of the world?s most profitable industries but is under increasing price and margin pressure from ever more cost conscious Governments and customers. An anticipated loss of approximately $78 billion in 2009 - 2014 resulting from patent cliffs, shrinking profit margins and increasingly heavy competition, growing regulatory pressure due to highly publicized drug dangers, recurring threats of litigation over real or perceived drug side effects, shifting demographic trends in both western and emerging markets, driving the demand for more and better pharmaceuticals and growing threats to intellectual property. These are the challenges the global pharmaceutical industry is facing today. To address these issues and minimize their negative impact to the extent possible, pharmaceutical firms are proactively and significantly changing their business models. One important strategic response to this has been to outsource, they are increasingly leveraging outsourcing to enable focused excellence on the core business of pharmaceuticals while abating the above issues. This article focuses on the outsourcing strategies of pharmaceutical manufacturers are evolving in today?s dynamic and challenging environment. In the course of research, companies use outsourcing partnerships to overcome challenges and achieve competitive advantage.

Biography :

I am Anand Manne currently in Ist M. Pharm- Pharmaceutical Regulatory Affairs in jss college of pharmacy, mysore. I have completed my bachelors in pharmacy from Manipal College of Pharmaceutical Sciences and have attended and volunteered for various conferences and seminars.